Adults 18 years and older with overweight or obesity and without type 2 diabetes may qualify for a study evaluating investigational medications designed to support weight management.
Obesity
Age Range:
18
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This clinical research study is evaluating investigational medications called macupatide and eloralintide, given as injections, to understand their potential to support weight reduction. These treatments are being studied both alone and in combination to assess their safety and effectiveness in adults without type 2 diabetes.
Qualifications
You may be able to join if you:
-Are 18 years of age or older
-Have overweight or obesity (BMI ≥30 kg/m², or ≥27 kg/m² with a related health condition)
-Do not have a diagnosis of type 2 diabetes
-Have not used certain weight-loss medications or similar treatments within the past 6 months
-Are able and willing to attend regular study visits and follow study procedures
FEATURED STUDIES
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]
Adults 18 and older who have had daily moderate to severe low back pain for at least 3 months may […]
Adults living with obesity, or overweight with a weight-related health condition, may qualify for a clinical research study evaluating an […]
Adults 18 years and older with overweight or obesity and without type 2 diabetes may qualify for a study evaluating […]
Adults with osteoarthritis (OA) knee pain may qualify for a research study evaluating an investigational medication for chronic pain relief.
Adults 18 to 75 years of age may qualify for a research study evaluating an investigational medication for migraine attacks.